• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Oncocyte Corporation - Common Stock (NQ:OCX)

3.200 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 3.200
Bid (Size) 3.080 (1)
Ask (Size) 3.240 (1)
Prev. Close 3.200
Today's Range 3.200 - 3.200
52wk Range 3.200 - 3.200
Shares Outstanding 13,368,387
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
OCX Stock Earnings: OncoCyte Beats EPS, Misses Revenue for Q2 2024 ↗
August 08, 2024
OCX stock results show that OncoCyte beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
OncoCyte’s (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Via AB Newswire

Performance

More News

Read More
News headline image
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Via News Direct
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Via TheNewswire.com
News headline image
OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q1 2024 ↗
May 15, 2024
Via InvestorPlace
News headline image
Earnings Scheduled For May 12, 2025 ↗
May 12, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
April 01, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
March 26, 2025
Via Benzinga
News headline image
Earnings Scheduled For March 24, 2025 ↗
March 24, 2025
Via Benzinga
News headline image
Earnings Scheduled For November 12, 2024 ↗
November 12, 2024
Via Benzinga
News headline image
What to Expect from OncoCyte's Earnings ↗
November 11, 2024
Via Benzinga
News headline image
4 Analysts Assess OncoCyte: What You Need To Know ↗
May 16, 2024
Via Benzinga
News headline image
3 Penny Stocks That Insiders Are Buying
May 07, 2024
Via MarketBeat
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
April 23, 2024
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
April 15, 2024
Via InvestorPlace
News headline image
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗
April 15, 2024
Via Benzinga
News headline image
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
April 15, 2024
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
April 12, 2024
Via Benzinga
News headline image
OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q4 2023 ↗
April 12, 2024
Via InvestorPlace
News headline image
Top 3 Health Care Stocks That May Collapse In Q2 ↗
April 12, 2024
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
April 12, 2024
Via InvestorPlace
News headline image
Earnings Scheduled For April 12, 2024 ↗
April 12, 2024
Via Benzinga
News headline image
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket ↗
April 12, 2024
Via Benzinga
News headline image
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
November 09, 2023
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
November 09, 2023
Via Benzinga

Frequently Asked Questions

Is Oncocyte Corporation - Common Stock publicly traded?
Yes, Oncocyte Corporation - Common Stock is publicly traded.
What exchange does Oncocyte Corporation - Common Stock trade on?
Oncocyte Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Oncocyte Corporation - Common Stock?
The ticker symbol for Oncocyte Corporation - Common Stock is OCX on the Nasdaq Stock Market
What is the current price of Oncocyte Corporation - Common Stock?
The current price of Oncocyte Corporation - Common Stock is 3.200
When was Oncocyte Corporation - Common Stock last traded?
The last trade of Oncocyte Corporation - Common Stock was at 06/17/25 04:00 PM ET
What is the market capitalization of Oncocyte Corporation - Common Stock?
The market capitalization of Oncocyte Corporation - Common Stock is 42.78M
How many shares of Oncocyte Corporation - Common Stock are outstanding?
Oncocyte Corporation - Common Stock has 43M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap